ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 528 filers reported holding ASTRAZENECA PLC in Q2 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $6,000 | 0.0% | 180 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $6,000 | 0.0% | 180 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $6,000 | 0.0% | 180 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $6,000 | +20.0% | 180 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $5,000 | -88.4% | 180 | -86.4% | 0.00% | -88.5% |
| Q3 2016 | $43,000 | +7.5% | 1,321 | 0.0% | 0.03% | +4.0% |
| Q2 2016 | $40,000 | -97.9% | 1,321 | -95.2% | 0.02% | -84.7% |
| Q1 2015 | $1,881,000 | -7.1% | 27,489 | -4.4% | 0.16% | -1.8% |
| Q4 2014 | $2,024,000 | -75.8% | 28,764 | -75.4% | 0.17% | -75.6% |
| Q3 2014 | $8,359,000 | -4.5% | 117,003 | -0.7% | 0.68% | +3.0% |
| Q2 2014 | $8,756,000 | -0.4% | 117,832 | -13.0% | 0.66% | -2.8% |
| Q1 2014 | $8,787,000 | -8.8% | 135,439 | +26.6% | 0.68% | -6.6% |
| Q4 2013 | $9,630,000 | +3.4% | 106,975 | -40.3% | 0.73% | -13.3% |
| Q3 2013 | $9,309,000 | – | 179,261 | +4.4% | 0.84% | – |
| Q2 2013 | $0 | – | 171,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |